Genomma Lab Internacional, S.A.B. de C.V.
General ticker "GNMLF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.2B (TTM average)
Genomma Lab Internacional, S.A.B. de C.V. does not follow the US Stock Market performance with the rate: -36.6%.
Estimated limits based on current volatility of -0.0%: low 0.96$, high 0.96$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-09-18, amount 0.01$ (Y2.09%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.01$, 2.01$]
- 2025-12-31 to 2026-12-31 estimated range: [0.97$, 1.91$]
Short-term GNMLF quotes
Long-term GNMLF plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | MXN892.41MM |
| Operating Expenses | MXN704.28MM |
| Operating Income | MXN188.13MM |
| Non-Operating Income | MXN-49.47MM |
| Interest Expense | MXN887.80MM |
| Income(Loss) | MXN138.66MM |
| Taxes | MXN38.37MM |
| Profit(Loss)* | MXN1,493.12MM |
| Stockholders Equity | MXN11,588.59MM |
| Assets | MXN1,103.96MM |
| Operating Cash Flow | MXN3,033.72MM |
| Capital expenditure | MXN12.99MM |
| Investing Cash Flow | MXN-731.97MM |
| Financing Cash Flow | MXN-1,591.04MM |
| Earnings Per Share** | MXN1.53 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.